Prospective, Rand, Open-label, Single-center, 2 Sequence, 3 Period Crossover Study to Compare the Steady State PK of Once-Daily-Extended Release LCP-Tacro to Generic Tacrolimus Capsules Twice Daily in Stable A A Renal Transplant pt.
Phase of Trial: Phase III
Latest Information Update: 05 Jun 2019
Price : $35 *
At a glance
- Drugs Tacrolimus (Primary) ; Tacrolimus
- Indications Renal transplant rejection
- Focus Pharmacogenomic; Pharmacokinetics; Registrational
- Acronyms ASERTAA
- Sponsors Veloxis Pharmaceuticals
- 31 Aug 2018 Biomarkers information updated
- 28 Mar 2018 Results presented in the Veloxis Pharmaceuticals media release.
- 28 Mar 2018 According to a Veloxis Pharmaceuticals media release, results from this trial were published in the American Journal of Kidney Diseases, Mar 2018 issue.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History